Favipiravir Other names: T-705

Chemical formula: C₅H₄FN₃O₂  Molecular mass: 157.104 g/mol  PubChem compound: 492405

Therapeutic indications

Favipiravir is indicated for:

Influenza A virus subtypes H1N1, H5N1, H7N9

Population group: only adults (18 - 65 years old)

at least one of
Influenza A (H1N1)
Influenza caused by Influenza A virus subtype H5N1
Influenza caused by Influenza A virus subtype H7N9

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Favipiravir is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Medication Package Insert (MPI) : AVIGAN Tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈